Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in astrazeneca pharma

AstraZeneca To Apply For Covid-19 Vaccine Approval In US Later In 2021

The timeline for the USFDA application has been in the works since the end-March when AstraZeneca released the data from its clinical trials of the COVID-19 vaccine in the US.

Read More

Getting Free, Affordable and Quality Healthcare is a Fundamental Right: Adar Poonawalla

It is now very clear that if you wait two and a half to three months between the first and the second dose, the efficacy is more than 80 per cent for the Oxford-AstraZeneca product

Read More

AstraZeneca Gets DCGI Nod For Asthma Drug

The company has received approval from the DCGI for Fasenra (Benralizumab solution for injection in a single dose prefilled syringe30 mg/ml) for patients with severe asthma (eosinophilic asthma)

Read More

AstraZeneca Pharma Gets DCGI Nod To Market Asthma Drug

AstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt of related statutory approvals and licenses.

Read More

AstraZeneca Must Prove Claim To Cheapest COVID-19 Vaccine

AstraZeneca has said it will not profit from sales of its vaccine, the price of which has been set at about $3 per dose, against at least four times more for other candidates.

Read More

AstraZeneca's COVID-19 Vaccine To Begin Clinical Trials In China

The vaccine candidate is already in the final stage of clinical trials in other countries, and AstraZeneca and its partner on the project, the University of Oxford, expect data from the late-stage trials this year.

Read More

Global Shares Slip As Coronavirus Worries Overshadow Positive China Data

The broader Euro STOXX 600 fell 0.4% in early trading, with bourses in Frankfurt, London and Paris all down by a similar margin.

Read More

EU Agency Recommends AstraZeneca-Merck Drug Lynparza For Two Cancers

Prostate cancer is the second-most common type of cancer in men worldwide, while ovarian cancer is the fifth most common cause of cancer death in Europe.

Read More

AstraZeneca Shares Gain As Coronavirus Vaccine Trials Resume

AstraZeneca shares were trading at 8,431 pence by 0833 GMT. UK pharma stocks, however, underperformed the FTSE 100, with GSK down 0.2% and Hikma 1% on Trump's order.

Read More

AstraZeneca Pauses Coronavirus Vaccine Trial As Participant Illness Investigated

Germany's Leukocare, which is working on a vaccine similar to AstraZeneca's but at an earlier stage, agreed that safety issues are likely to crop up in large trials.

Read More

Weak Global Cues Drag Down Equity Indices, Banking Stocks Suffer

The BSE S&P Sensex closed 171 points or 0.45 per cent lower at 38,194 while the Nifty 50 was down by 39 points or 0.35 per cent at 11,278.

Read More

AstraZeneca Puts Leading COVID-19 Vaccine Trial On Hold Over Safety Concern

Shares of AstraZeneca fell more than 8% in after-hours U.S. trading, while shares of rival vaccine developers rose. Moderna Inc was up more than 4% and Pfizer Inc rose less than 1%.

Read More

AstraZeneca Starts Trial Of Antibody Treatment For COVID-19

The trial will evaluate if AZD7442, a combination of two monoclonal antibodies, is safe and tolerable in up to 48 healthy participants between the ages of 18 and 55 years in the United Kingdom with the backing of the United States.

Read More

AstraZeneca Signs First COVID-19 Vaccine Supply Deal With Chinese Company

To meet market demand in China, Shenzhen Kangtai will ensure it has annual production capacity of at least 100 million doses of the experimental shot AZD1222

Read More

Next Big COVID-19 Treatment May Be Manufactured Antibodies

Scientists are still working out the exact role of neutralizing antibodies in recovery from COVID-19, but drugmakers are confident that the right antibodies or a combination can alter the course of the disease that has claimed more than 675,000 lives globally.

Read More